Veracyte Funding & Investors
South San Francisco, CA
Veracyte, Inc. develops molecular tests for oncology. The Company offers molecular cytology and tests for the diagnostic accuracy of cytology samples. Veracyte provides its products and services to healthcare and molecular diagnostic companies in the United States.
https://www.veracyte.com/Total Amount Raised: $1,098,150,016
Veracyte Funding Rounds
Post Ipo Equity
$550,000,000
Post Ipo Equity
$194,000,000
Post Ipo Equity
$137,800,000
Post Ipo Equity
$55,100,000
Post Ipo Equity
$30,000,000
Post Ipo Debt
$45,000,000
Post Ipo Debt Investors
Madryn Health PartnersDebt Financing
$15,000,000
Debt Financing Investors
Armentum PartnersSeries C
$28,000,000
Series C Investors
GE VenturesKleiner PerkinsTPG BiotechDomain AssociatesVersant VenturesIPO
Unknown
Series Unknown
$14,950,000
Series Unknown Investors
Domain AssociatesKleiner PerkinsSeries B
$28,000,000
Series B Investors
Domain AssociatesTPG BiotechKleiner PerkinsVersant VenturesSeries A
$300,000
Funding info provided by Diffbot.